Seeing Is Believing
Currently out of the existing stock ratings of Gary Lieberman, 6 are a HOLD (60%), 2 are a SELL (20%), 2 are a BUY (20%).
Analyst Gary Lieberman, currently employed at CAPITAL ONE, carries an average stock price target met ratio of 100% that have a potential upside of 2.38% achieved within 52 days. Previously, Gary Lieberman worked at WELLS FARGO.
Gary Lieberman’s has documented 13 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on DGX, Quest Diagnostics at 20-Oct-2017.
Analyst best performing recommendations are on DGX (QUEST DIAGNOSTICS).
The best stock recommendation documented was for DGX (QUEST DIAGNOSTICS) at 10/12/2017. The price target of $88 was fulfilled within 49 days with a profit of $6.07 (7.41%) receiving and performance score of 1.51.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$200
$22.05 (12.39%)
$180
12 days ago
(28-Apr-2025)
5/7 (71.43%)
$23.32 (13.20%)
196
Buy
$194
$16.05 (9.02%)
$191
17 days ago
(23-Apr-2025)
23/26 (88.46%)
$20.43 (11.77%)
336
Hold
$180
$2.05 (1.15%)
$165
17 days ago
(23-Apr-2025)
4/5 (80%)
$6.43 (3.70%)
252
Hold
$190
$12.05 (6.77%)
$182
17 days ago
(23-Apr-2025)
15/17 (88.24%)
$16.43 (9.47%)
397
Buy
$189
$11.05 (6.21%)
$178
1 months 1 days ago
(09-Apr-2025)
21/23 (91.3%)
$24.94 (15.20%)
482
What Year was the first public recommendation made by Gary Lieberman?